Although lifestyle modification is the first reference treatment for T2D, modifying the patient’s habits is often ineffective to stabilize glycemia and combinations of pharmacological treatments (metformin, sulfonylurea, incretin enhancers, GLP-1 mimetics, etc.)are often required to treat T2D [2,3]. This evidence concerns the gene GCG and type 2 diabetes mellitus.